← Leaderboards
Baoli Hu
University Of Pittsburgh At Pittsburgh
$3,556,083
Attributed
$3,556,083
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,556,083 · 3
By mechanism
R01$3,121,958 · 2
R21$434,125 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joseph W Yip$1,510,859
- Rebecca P Hughey$3,582,198
Others in their field
Other Emerging Leaders on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$250,731,514
Research focus
United States National Institutes Of HealthLoss Of FunctionPublic HealthTumorPathway InteractionsCellsMediatingProgramsSignal TransductionIn VivoMouse ModelMolecularMissionIn VitroBrainEffective TherapyBrain NeoplasmsPhenotypeInnovationNovel Therapeutic InterventionNeoplastic CellOverexpressionMigrationBinding
Grant awards (8)
Role of SMARCD3/BAF60C in medulloblastoma$579,244
R01 · FY2025 · NS · contact PI
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma$496,239
R01 · FY2025 · CA · contact PI
Role of SMARCD3/BAF60C in medulloblastoma$644,967
R01 · FY2024 · NS · contact PI
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma$462,773
R01 · FY2024 · CA · contact PI
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma$483,859
R01 · FY2023 · CA · contact PI
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma$454,876
R01 · FY2022 · CA · contact PI
Role of SMARCD3/BAF60C in neurodevelopment and medulloblastoma$198,750
R21 · FY2022 · NS · contact PI
Role of SMARCD3/BAF60C in neurodevelopment and medulloblastoma$235,375
R21 · FY2021 · NS · contact PI